SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vector1 who wrote (8294)2/23/2001 11:11:21 PM
From: rkrw   of 9719
 
<<<TD, thanks for the detailed info. I think I will wait for a pullback. I am also going to give my Dr. a call and see what he thinks. I will report back.
V1 >>>

An FYI for those interested in inkp (big discussion here a few months back).

I finally had a chance to ask my gastroenterologist about the INKP pills today. He knew all about inkp and their pills. He was an emphatic thumbs down. I guess they had told him some time prior to this recent approval that their regimen was to be 5-7 pills with a much more convenient regimen. The actual regimen turned out to be pills every half hour starting the night before for a total of 40 pills. He seemed upset about that discrepancy. He's essentially not prescribing, thinks it's less convenient to patients, thinks the pill burden is absurd and patients end out drinking more water alone than they would fluid. To date, he said he's prescribed it for 2 patients, which probably translates to less than 1% market share (my guess).
I've also had a colonoscopy, drank the fluid (awful) but about half the gallon did the trick. I guess it's deal with the liquid. Oh well.
If my Doctor's feedback is typical, it's no wonder inkp recently signed P&G to head a direct to consumer marketing campaign.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext